Reumatoloxía

2017

1. * Human Amniotic Mesenchymal Stromal Cells as Favorable Source for Cartilage Repair

   Tissue engineering. Part A, Vol. 23, Núm. 17-18, pp. 901-912

2. 2016 update of the EULAR recommendations for the management of early arthritis

   Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 948-959

3. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

   American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

4. A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis /692/699/1670 /692/4023/1670/595 article

   Scientific Reports, Vol. 7, Núm. 1

5. A multicentric study to evaluate the use of relative retention times in targeted proteomics

   Journal of Proteomics, Vol. 152, pp. 138-149

6. A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

   Annals of the Rheumatic Diseases, Vol. 76, Núm. 9, pp. 1598-1602

7. A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis

   Rheumatology International, Vol. 37, Núm. 8, pp. 1347-1356

8. A replication study and meta-analysis of mitochondrial DNA variants in the radiographic progression of knee osteoarthritis

   Rheumatology (United Kingdom), Vol. 56, Núm. 2, pp. 263-270

9. A survey of anatomical items relevant to the practice of rheumatology: pelvis, lower extremity, and gait

   Clinical Rheumatology, Vol. 36, Núm. 12, pp. 2813-2819

10. Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient

    Journal of Orthopaedic Research, Vol. 35, Núm. 6, pp. 1299-1303

11. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

    Scientific Reports, Vol. 7

12. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest

    Clinical Biochemistry, Vol. 50, Núm. 16-17, pp. 903-910

13. Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients

    PLoS ONE, Vol. 12, Núm. 7

14. Anti–Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients

    Arthritis and Rheumatology, Vol. 69, Núm. 3, pp. 668-675

15. Biodistribution and immunogenicity of allogeneic mesenchymal stem cells in a rat model of intraarticular chondrocyte xenotransplantation

    Frontiers in Immunology, Vol. 8, Núm. NOV

16. CD105+-mesenchymal stem cells migrate into osteoarthritis joint: An animal model

    PLoS ONE, Vol. 12, Núm. 11

17. Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts

    Medicine (United States), Vol. 96, Núm. 26

18. Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 7, pp. 1263-1268

19. Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 35, pp. S114-S121

20. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    Arthritis and Rheumatology, Vol. 69, Núm. 1, pp. 77-85